Dr. Reddy's Laboratories reported its highest-ever quarterly revenue in Q2, yet brokerages maintain a neutral stance due to a lack of a strong drug pipeline. Despite increased R&D spending on biosimilars and generics, firms like Nuvama and Jefferies express concerns over the absence of major product launches, leading to reduced stock ratings and target prices of Rs 1,215 and Rs 1,130, respectively.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
